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1 Introduction
Since the occurrence of plasma volume deple-
tion represents a typical pathophysiological fea-
ture in preeclampsia [5, 7, 10], several groups
have demonstrated favorable results in the
treatment with plasma volume expanders [4, 6,
8, 9, 18, 19, 20, 22].
During hypervolemic hemodilution with low
molecular dextran, both SCHWARZ and RETZKE
[19] and CLOEREN et al. [4] described increased
impulse rates using isotope techniques as an
index of elevated placental perfusion. In contra-
st, JOUPPILA et al. [12] estimated no improve-
ment of placental perfusion in the course of a
100 ml infusion of 20% human albumin.
For the early detection of heart decompensa-
tion attributed to fluid overload during plasma
expander therapy intensive surveillance is rec-
ommended [4]. In previous studies [22] we could
demonstrate that alterations in maternal cardi-
ac output as well as the fluid intake in the lungs
can be continuously monitored by means of
noninvasive thoracic impedance cardiography.
The interest in developing noninvasive methods
for fetal blood flow measurements has gradu-
ally increased. Meanwhile pulsed doppler ultra-
sonography offers the possibility of estimating
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data on fetal blood flow characteristics [3, 11,
14].
The subject of the following investigation was
to combine both thoracic impedance cardiogra-
phy and pulsed doppler ultrasonography for
the simultaneous noninvasive estimation of ma-
ternal and fetal hemodynamics during hypervo-
lemic hemodilution in preeclampsia. In humans
the simultaneous monitoring of both hemody-
namic systems has not been focused as yet.
2 Material and methods
This preliminary report summarizes the investi-
gations in five preeclamptic women in the last
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trimester of pregnancy. All patients were admit-
ted to hospital care with raised mean arterial
blood pressure (MAP > 103.3 mm Hg) and he-
moconcentration (hematocrit > 38%). The ul-
trasonographic estimation of the fetus in all
cases showed no anatomical malformations.
Patients' characteristics are summarized in
table I.
The antenatal fetal weight was estimated ac-
cording to the chest and head circumferences.
All patients were without any antihypertensive
drug treatment or diuretics. The basic treat-
ment consisted of bed rest prior to hypervolem-
ic hemodilution. Informed consent was obtain-
ed from all patients, who were included in this
study.
2.1 Clinical procedure
Hypervolemic hemodilution was performed
with 500ml low molecular dextran* intrave-
nously over a period of exactly 60 minutes.
Twenty ml of hapten** was preinjected to avoid
anaphylactic reactions.
Twentyfour hours after dextran application the
same patients received 500 ml physiologic saline
solution using the same conditions compared to
hypervolemic hemodilution with dextran. This
placebo-controlled procedure in intraindividual
comparison was performed to distinguish be-
tween specific dextran effects and nonspecific
effects of isovolemic hemodilution with NaCl
on the maternal and fetal circulatory system.
During dextran and NaCl supply, the following
hemodynamic parameters were monitored in
15-minutes intervals:
maternal: heart rate, blood pressure, stroke
volume, cardiac output (calculated
as cardiac index);
fetal: heart rate, flow velocity and flow
volume in the descending aorta and
umbilical vein.
In the following 60-minutes period after the
end of infusion these measurements were re-
peated at 15 minutes (p 15), 30 minutes (p 30)
and 60 minutes (p 60). In each patient a total
of eight measurements were carried out for
both dilution regimen. All hemodilutions were
performed at the same daytime (afternoon) to
avoid possible undesired side effects due to
maternal and fetal circadian rhythm.
2.2 Technical equipment
Maternal hemodynamics: We used the IFM Im-
pedance Cardiograph, model 400*. ECG,
phonocardiogram, the impedance signal delta
Z and its first derivate dZ/dt were recorded via
a multichannel plotter. Beat-to-beat calcula-
tions of isolated stroke volume and the cardiac
output were estimated with a büilt-in ZCG-
Computer*. This computer was triggered by
two potentiometers, which indicate the respec-
tive distances of the internal electrode bands
and the specific hematocrit-dependent resist-
ance of blood [15]. Heart rate was derived from
the ECG-recordings.
* Rheomakrodex®, **Promit®, Marketing: Knoll AG,
Ludwigshafen, FRG * Marketing: Diefenbach GmbH, Frankfurt, FRG
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Table II. Summary of maternal hemodynamic parameters during dextran 40 and NaCl supply.

























































Cardiac Index 3.20(0.70) 3.29(0.80) 3.24(0.90) 3.34(0.76) 3.20(0.70) 3.15(0.66) 3.21(0.59) 3.15(0.50)
(L/min, m2)
Fetal hemodynamics: Simultaneously to ma-
ternal hemodynamic monitoring we investi-
gated fetal blood flow characteristics, using an
ADR Kranzbühler model 8130 DUPLEX**. This
equipment consisted of a 3.5 MHz realtime
scanner in combination with a 2 MHz pulsed
doppler. The realtime image and the doppler
spectrum were displayed simultaneously (see
figures 1 and 2). The angle between the doppler
beam and the linear array was fixed at 50°. The
flow measurements were evaluated offline from
frozen images, in which the vessels' diameters
were determined by focussing the respective
area of measurement (see figures 1 and 2). The
instrument calculated the flow velocity (cm/sec)
and the corresponding blood flow volume (ml/
min) from the doppler spectrum over an adjust-
able time interval (i. g. one heart cycle).
Following the placement of the impedance elec-
trode bands and taking the supine position, the
patients were kept resting until reproducible
measurements of maternal and fetal cardiac
output could be obtained prior to hemodilu-
tion.
** Marketing: Squipp Medical Systems, Solingen, FRO
J. Pcrinat. Mcd. 14(1986)
2.3 Statistics
Statistical analysis included the Student's t-test
for paired observations. The correlation coeffi-




Hypervolemic hemodilution with 500ml dex-
tran induced an increase in cardiac index which
was mainly due to elevated stroke volume. Be-
at-to-beat registration of isolated stroke volume
revealed an increase from 69.9 ml prior to infu-
sion to 83.6 ml 45 minutes after the beginning
of plasma volume expansion. In the following
period up to 60 minutes post infusionem, both
the cardiac index and the stroke volume slightly
decreased but did not reach the respective va-
lues at rest prior to hypervolemic hemodilution.
No remarkable changes in maternal heart rate
and mean arterial blood pressure were found
during the total period of investigation. In the
course of normovolemic hemodilution with
0.9% NaCl the intraindividual comparison for
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all parameters showed no statistically signifi-
cant differences throughout the 120 minutes
period.
Table II summarizes the mean values (x) and
standard deviations (SD) for heart rate, stroke
volume and cardiac index for both dextran and
NaCl procedures.
4.2 Fetal hemodynamics
As an exemplary illustration figures 1 and 2
show the original recordings of doppler shifts
in case 3 (Pat. F. R.) at three different times
during hypervolemic hemodilution: prior to in-
fusion, 30 minutes after the beginning and fi-
nally 60 minutes after the end of dextran appli-
cation.
In this case fetal blood flow parameters could
be investigated in the descending aorta (figure
2) as well as in the umbilical vein (figure 1).
The alterations in fetal hemodynamics in this
patients are representive for our general experi-
ence in all cases. During hypervolemic hemodi-
lution we found a significant increase in blood
Figure 1. Original tracing of doppler shift at a) time 0
(prior to infusion), b) time 30 during dextran applica-
tion, c) time p 60 (60 minutes after dextran supply) in
the fetal V. umbilicalis.
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velocity which was also evident within the foll-
ow-up period of 60 minutes after dextran sup-
ply. Aortic flow volume rose from 216ml/min,
kg to 268 ml/min, kg at time p 15 and remained
nearly unchanged till the end of observation.
During NaCl infusion no significant changes in
fetal circulation could be exhibited. The results
are summed up in Table III.
Figure 3 illustrates the percent changes in ma-
ternal cardiac index and fetal aortic flow vol-
ume/kg body weight in comparison between
dextran and NaCl supply. In the course of
maternal plasma volume expansion both circu-
latory systems react with an increase in cardiac
output. In fetal cardiovascular system this
effect is maintained till 60 minutes after the end
of dextran infusion (p 60), whereas maternal
cardiac output constantly decreases within p 15
and p 60.
Fetal blood flow velocity in the descending
aorta and maternal cardiac index strongly cor-
relate (figure 4) on the analysis of the mean
values of both parameters during hypervolemic
hemodilution.
Figure 2. Original tracing of doppler shift at a) time 0
(prior to infusion), b) time 30 during dextran applica-
tion, c) time p 60 (60 minutes after dextran supply) in
the fetal A. dcsccndens.
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Table HI. Summary of fetal hemodynamic parameters during dextran 40 and NaCl supply.
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Figure 3. Percent changes of maternal and fetal hemo- Figure 4. Correlation between maternal cardiac index
dynamic parameters in the course of dextran and isoto- and fetal blood flow velocity during hypervolemic hemo-
noc NaCl supply. dilution with dextran.
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4 Discussion In animal experiments SCHR CK et al. [17] in-
The objective of this study was to assess circula- ****** the influencef °f aCUte ff*™* he"
tory effects of hypervolemic hemodilution in ^dilution on pregnant ewe circulation^ JOUP-
*™^ΐο™™;«, r u +u Λ Λ r * \\τ PILA et al. [12] demonstrated nearly unchangedpre-eclampsia for both mother and fetus. We . . .„ * -
 Λ · 1U · - c ·j + - - * u j u· -L r intervillous perfusion during albumin infusion,
used two nomnvasive methods which so far ^u ,f . , * ^ . ,u r+ u· Λ *·ι η Λ * i. · These results are in contrast to those from
were not combined until now. Both techniques
 c * i nm u· u · u* u Λ +Λ . · « ,. , j i j SCHWARZ et al. [19], which might be due to
— thoracic impedance cardiography and pulsed ,.— * n. *· · * ι j- * +
* ι / u· <. Λ ι different alterations in maternal cardiac outputdoppler/realtime transducer — are complemen-
 u . « , A<\ A n~ ·
.
 A > u · · t. r between dextran 40 and albumin,tary and appear to be a promising approach for
noninvasive estimation of maternal and fetal During hypervolemic hemodilution we estimat-
circulation. Thoracic impedance cardiography ed an increase in fetal blood flow velocity and
is easy to perform and particularly suited for flow volume in the umbilical vein and in the
the determination of changes in cardiac per- descending aorta. From these results it can be
formance during a longtime period. This tech- concluded that an elevated maternofetal fluid
nique enables the interindividual study of circu- exchange could occur, although low molecular
latory effects of different therapeutic proce- dextran does not pass the placenta [13].
dures such as fluid therapy. In previous studies
 T t ~ ., , ,,, M1 , tΓ0.Ί . , Τ *· Γ Λ CM · In general, fluid exchange at the capillary level[21] we estimated a correlation of r = 0.81 in . f
 A · * « A, <.. , * * * *..1
 Λ. . ,
 u . , ,. is determined by the oncotic and hydrostaticcardiac output between impedance cardiogra- ,. J. .... ^ .,/ . ,
u Λ ^ ^ j-i 4.· Λ ^ - pressure gradients within the capillaries andphy and the thermodilution method using f, to ,. Λ -^ -^u · *ο Α- Λ · * Λ * the surrounding tissue fluids. These interactionsSwan-Ganz thermistor catheter.
 t - Λ * ι ^ ι ·* Α ^·also occur in the uteroplacental unit. According
Fetal blood flow measurements with pulsed to the Hagen-Poiseuille law, vessel blood flow
doppler equipment maintain potential sources 1S determined by the pressure gradient and the
of errors, especially the correct determination vessel diameter. The regulation of blood volume
of vessel diameter and the accuracy in finding between the fetus and the placenta is controlled
the optimal angle between doppler beam and bY the different pressure gradients between
fetal vessel [3]. This study protocol was de- placental blood flow and the umbilical vessels
signed as an intraindividual longitudinal study; PQ- In cases of preeclampsia, BENEDETTI and
the individual vessel diameter remained con- CARLSON [2] described maternal colloidosmotic
stant within the whole period of investigation pressure to be significantly lower than in nor-
and the angle between doppler stream and ves- motensive pregnancies. The normal range of
sei wall was in the range between 43° and 63° maternofetal colloidosmotic pressure gradient
(mean: 53.1° + 4.5°). *s a^out 52 mm EbO [17] and rises up to 92 mm
~~ HbO in cases with preeclampsia and intrauter-
In pre-eclampsia, maternal hemodynamics are ine growth retardation [17]. In pregnant ewes,
characterized by a lack of plasma volume ex- stepwise hypervolemic hemodilution with albu-
pansion and a raised total peripheral resistance min leads to a slight fetal hemodilution, which
[8], Elevated hematocrit is a good indicator of can be identified by a further decrease in fetal
deficient plasma expansion [10]. In contrast to colloidosmotic pressure [17]. The elevated hy-
ASSALI et al. [1] we support the opinion of drostatic intervillous pressure, induced by plas-
GROENENDUK et al. [8] that plasma expansion ma volume expansion might be responsible for
in pre-eclampsia is of potential benefits to the net flow of water into the fetal circulation,
maintain a normal cardiac index such as the Nevertheless improved blood flow properties in
physiological conditions in normal pregnancy, the course of plasma expander therapy may
Hemodilution with oncotic active drugs also also play an additive role in the fetoplacental
improves blood flow behavior in microcircula- water transfer. Further studies are warranted
tion [9]. to support these preliminary experiences.
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Summary
In pre-eclampsia hemodynamic alterations are charac-
terized by a lack of plasma volume expansion and a
raised peripheral vascular resistance.
For the compensation of plasma volume deficit and to
restitute blood fluidity the therapeutic use of plasma
volume expanders (f. e. low molecular dextran) is recom-
mended. Several groups (GooDLiN et al. [6], CLOEREN et
al. [4], HEILMANN et al. [9], SEGHAL et al. [20], SCHRÖCK
[18]) have demonstrated benefitial effects on fetal status
and development in the course of hypervolemic hemodi-
lution in preeclampsia.
This therapeutic procedure presumes the continuous sur-
veillance of maternal hemodynamics to early recognize
heart insufficiency or fluid overload in the lungs. We
use the noninvasive thoracic impedance cardiography
for continuous monitoring of maternal heart perform-
\ ance.
The effect of hypervolemic hemodilution on fetal circula-
tion has not been quantitatively investigated yet. Mean-
while pulsed doppler ultrasonography offers the possi-
bility of estimating quantitative changes on fetal blood
flow. We used both noninvasive techniques — thoracic
impedance cardiography and pulsed doppler imaging
system — for the simultaneous evaluation of maternal
and fetal hemodynamic parameters during hypervolemic
hemodilution.
This preliminary report summarizes the investigations
in 5 patients with pre-eclampsia (mean arterial blood
pressure > 103.3 mm Hg, hemoconcentration with elev-
ated hematocrit levels > 38%). The patients received
an infusion of 500 ml dextran 40 over a period of exactly
60 minutes. The simultaneous measurements of maternal
and fetal cardiovascular parameters were performed in
15-minutes intervals during dextran application and 15
minutes (p 15), 30 minutes (p 30) and 60 minutes (p 60)
after the end of infusion.
Twentyfour hours after dextran application the same
patients received 500ml physiological saline infusion
under the identical conditions to distinguish between
dextran specific and nonspecific effects of maternal he-
modilution in iiitraindividual comparison.
Results: Hypervolemic hemodilution with dextran 40
induced a significant increase in maternal cardiac index,
the maximum values of cardiac index were registrated
45 minutes after the starting of infusion. In the following
60 minutes after the end of dextran supply cardiac index
slightly decreased.
During the infusion of 500 ml 0.9% NaCl solution ma-
ternal cardiac index at all times remained nearly un-
changed. Maternal heart rate and mean arterial blood
pressure showed no remarkable alterations for both he-
modilution regimen.
Fetal aortic blood flow velocity significantly increased
during and after dextran application. Fetal aortic blood
flow volume also showed a significant increase (+ 20%)
and remained elevated up to 60 minutes after the end
of infusion. Original recordings of fetal doppler shifts
(aorta descendens, vena umbilicalis) are giving evidence
of the investigated data.
Fetal blood flow velocity in the descending aorta and'
maternal cardiac index strongly correlated (r = 0.908).
In contrast during and after NaCl infusion no quantita-
tive changes in fetal flow velocity and flow volume could
be exhibited.
Discussion: These preliminary observations indicate that
hypervolemic hemodilution in preeclampsia correlate
with a rise in fetal blood flow velocity and flow volume.
This fact might be due to elevated uteroplacental perfu-
sion via raised maternal cardiac output. In intraindividu-
al comparison nonnovolemic hemodilution do not dem-
onstrate similar effects.
In accordance to animal studies (SCHRÖCK, [17]) plasma
volume expansion leads to elevated hydrostatic intervil-
lous pressure, which might be responsible for the net
flow of water into fetal circulation. Further studies are
warranted to support these first experiences.
Keywords: Fetal blood flow characteristics, impedance cardiography, plasma volume expansion in preeclampsia,
pulsed Doppler ultrasound.
Zusammenfassung
Simultane Vergleichsuntersuchungen zur maternalen und
fetalen Herzauswurfleistung unter hypervolämischer Hä-
modilution bei der Präeklampsie — Erste Ergebnisse
Die hämodynamischen Veränderungen bei der Prä-
eklampsie sind durch eine fehlende Plasmavolumen-Ex-
pansion in Verbindung mit einem pathologisch gesteiger-
ten peripheren Gefäßwiderstand gekennzeichnet.
Als Theologisch orientierte, die Fließeigenschaften des
Blutes verbessernde Therapiemöglichkeiten bieten sich
die parenterale Gabe von Plasmavolümenexpandern,
z. B. niedermolekulares Dextran an. Von verschiedenen
Arbeitsgruppen (GOODLIN et al. [6]; CLOEREN et al. [4];
HEILMANN et al. [9]; SEGHAL et al. [20]; SCHRÖCK [18])
ist der günstige Einfluß einer hypervolämischen Hämo-
dilutionsbehandlung auf die fetale Entwicklung bei der
Präeklampsie beschrieben worden.
Diese Therapie setzt jedoch die kontinuierliche kardio-
pulmonale Überwachung der Mutter zur frühzeitigen
Erkennung einer pulmonalen Überwässerung und einer
insuffizienten Herzauswurfleistung voraus. Zu diesem
Zweck führen wir eine Herz-Kreislaufüberwachung mit
Hilfe der nichtinvasiven thorakalen Impedanzkardiogra-
phie durch.
Neben den Veränderungen im mütterlichen Herzkreis-
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laufsystcm stellt die fetale Zirkulation unter diesem the-
rapeutischen Verfahren einen bisher noch nicht quantita-
tiv erfaßten Parameter dar. Die Kombination von Real-
Time-Sonographic mit gepulsten Doppier-Systemen er-
möglicht mittlerweile die quantitative Beurteilung fetaler
Flußgrößen über die Erfassung venöser und arterieller
Doppler-Gcschwindigkeitsprofile. In Verbindung von
thorakaler Impedanzkardiographie und gepulstem Dop-
pler-Verfahren werden erstmals zwei nicht invasive Me-
thoden kombiniert, um unter einer hypervolämischen
Hamodilution sowohl die maternale als auch fetale Ha-
modynamik erfassen zu können.
Diese Untersuchungen wurden bei 5 Patientinnen mit
Präeklampsie (mittlerer arterieller Blutdruck 103.3 mm
Hg, Hämokonzcntration mit Hkt-Werten 38%)durchge-
führt. 500 ml Rheomakrodex11 wurde in exakt 60 Minu-
ten parenteral appliziert, zusätzlich erfolgte nach Infu-
sionsende in der anschließenden Stunde zu drei Meßzeit-
punkten (p \ 5, p 30, p 60) die Kontrollmessung fetaler
und maternaler Kreislaufparameter. Innerhalb der Infu-
sionszeit wurden die Messungen in 15-Minuten-Abstän-
den durchgeführt.
24 Stunden nach hypervolämischcr Hamodilution er-
folgte bei den gleichen Patientinnen unter identischen
Meßbcdingungen eine isovolämische Hamodilution mit
500 ml NaCl im Sinne eines plazebo-kontrollierten in-
traindividuellen Kreuzversuches. Damit sollten nicht
dcxtranspezifische Einflüsse auf das mütterliche und fe-
tale Herzkreislaufsystem verifiziert werden. Auf die Ein-
haltung einer reproduzierbaren Ruhcmcßphase wurde in
allen Untersuchungen entsprechend Wert gelegt.
Ergebnisse: Die hypervolämische Hamodilution mit
Dextran 40 führte zu einer signifikanten Zunahme der
Herzauswurfleistung, die nach 45 Minuten ihr Maxi-
mum erreichte und nach Infusionscnde innerhalb der
einstündigen Kontrollpcriodc allmählich wieder abfiel.
Demgegenüber blieb der maternalc Herzindex während
und nach NaCl-lnfusion nahezu unverändert. Mütter-
liche Herzfrequenz und mittlerer arterieller Blutdruck
ergaben für die gesamte Meßzeit keine signifikanten
Veränderungen.
Die fetale aortale Flußgeschwindigkcit stieg unter Dex-
tran-Gabc schnell an und blieb auch im Anschluß an
die einstundige Infusionszeit weiterhin erhöht; hingegen
ließ sich unter NaCl-lnfusion keine signifikante Ände-
rung dieses Parameters nachweisen.
Die fetale aortale Herzauswiirilcistung in Form des ge-
wichtsbezogenen Flußvolumens stieg mit dem mütter-
lichen Herzindex innerhalb der ersten 30 Minuten unter
Dcxtran nahe/u parallel an. Im weiteren Verlauf bis zum
Mcßzeitpunkt p 60 ergab sich im fetalen Kreislauf eine
um 20% gegenüber dem Ausgangswert gesteigerte Aus-
wurfieistung.
Anhand von Originalregistricrungcn der Dopplcr-Shift-
Signale aus der Aorta dcscendens und Vena umbilicalis
unter hypervoliimischer Hamodilution werden diese Ver-
änderungen belegt. Die enge hämodymimische Bezie-
hung beider Kreisläufe spiegelt sich in der linearen Re-
gression (r 0.908) zwischen mütterlicher
Hcrzauswurfieistung und fetaler aortaler Flußgeschwin-
digkcit wider.
Diskussion: Diese ersten Ergebnisse, die mit Hilfe der
Kombination zweier nichtinvasiver Verfahren die simul-
tane Messung des mütterlichen und fetalen Herzkreis-
laufsystems gestattet, geben den Hinweis, daß die durch
eine Plasmavolumenexpansion induzierte Verbesserung
der uteroplazentaren Perfusion mit einer Erhöhung der
fetalen Hcr/auswurfleistung korreliert. Unter der Infu-
sion von physiologischer Kochsalzlösung gleichen Volu-
mens läßt sich im intraindividuellen Vergleich dieser
Effekt nicht nachweisen. Auch unter dem Vorbehalt des
noch kleinen Stichprobenumfangcs der hier dargelegten
Ergebnisse darf als vorläufiges Ergebnis festgestellt wer-
den, daß das Mehrangebot an intravasnlem Volumen in
Analogie zu ticrexpcrimentcllen Untersuchungen von
SCHRÖCK [17] über eine Erhöhung des maternofetalen
hydrostatischen Druckgradientcn zu einem in Richtung
Fet führenden Volumenaustausch mit entsprechender
Erhöhung des fetalen Blutvolumens und der fetalen
Blutströmungsgeschwindigkeit führt. Weitere Untersu-
chungen müssen diese ersten Erfahrungen untermauern.
Schlüsselwörter: Fetale Blutflußmessungcn, gepulster Doppier, hypervolämische Hämodilulion, Impedanzkardio-
graphie, Präeklampsie.
Resume
Les etudes simultaneous sur les systdmcs cardio-circulatoi-
res foteaux et maternels au cours de l'infusion hypcrvolc-
mic aux cas des prooclampsics
Dans la preeclampsie, les changements hemodynamiqucs
sont caracteriscs par un deficit du volume plasmatique
associo ä une elevation des resistances peripheriques.
D'un point de vuc rheologiquc, Tapplication parenterale
de «plasma-expander», se prosentc commc une des mcil-
leures therapcutiques cn vue de Pobtcntion d'une fiuiditc
optimale sanguine. D'apres diverses equipcs de recher-
che, (GoooLiN et co. [6]; CLOEREN et co. [4]; HEILMANN
et co. [9J; SEGIIAL et co. [20]; SCHRÖCK [18]) le traitcment
par hemodilution hypervolemiquc joue un role favorable
sur le dcveloppement foetal dans la preeclampsie.
Cettc thcrapic suppose ccpcndant, une surveillance per-
manente cardio-pulmonairc de la mere pour detccter
asscz tot les premiers signes d'oedcmc pulmonaire et
d'insufllsancc cardiaquu. Duns cette optique, nous me-
nons une surveillance cardio-circulatoirc grace a des
moyens non-invasifs d'«impcdancc cardiographic» tho-
racale.
A colc des changements dans le Systeme cardio-circulu-
J. Pcrinat. Mcd. 14 (1986)
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toire maternel, nous n'avons jusqu'a present aucune
valeur quantitative des variations du Systeme circulatoire
foetal engendrees par ce precede.
La combinaison de «Real-Time-Sonographie» et du Sys-
teme Doppier a autorise entretemps une appreciation
quantitative des debits fcetaux grace a la realisation de
proflls de vitesse Doppier veineux et arteriels. En paralle-
le avec l'impedance cardiographie thoracale et le princi-
pe du pouls «Doppier» seront d'abord combinees deux
methodes non-invasives, afin de pouvoir contröler lors
d'une hemolution hypervolemique tant Fhemodynami-
que maternelle que fcetale.
Ces examens furent menes aupres de 5 patientes en
preeclampsie (tension arterielle moyenne > 103,3 mm
Hg, hemoconcentration d'une valeur d'hematocrite >
38%). 500 ml de Rheomacrodex® furent appliques par
voie parenterale en-deans 60 minutes tres exactement;
de plus, dans les heures suivant cette infusion, nous
^avons etabli a trois moments precis (p 15, p 30, p 60)
des mesures de contröle des parametres circulatoires
fcetaux et maternels. Au cours de l'infusion, les mesures
ont ete effectuees toutes les 15 minutes. 24 heures apres
cette infusion hypervolemique, suivit chez ces memes
patientes et avec des memes conditions de mesure, une
hemodilution isovolemique a l'aide de 500 ml de NaCl
dans le but d'un essai de controle-placebo. Dans ce cas,
les effets specifiques occasionnes par les dextrans sur
les systemes cardio-circulatoires foetaux et maternels ne
seront pas observes.
Resultats: L'hemodilution hypervolemique avec du Dex-
tran 40 conduit a une augmentation de debit cardiaque
qui atteint son maximum apres 45 minutes et apres
infusion diminue graduellement toutes les heures oü on
le contröle. En contrepartie, l'index cardiaque maternel
reste inchange pendant et apres perfusion d'une solution
saline. Au moment de chacune de ces mesures, aucune
variation significative de frequence cardiaque et ce ten-
sion arterielle moyenne maternelles ne fut observee.
Le debit aortique foetal s'eleva rapidement sous adminis-
tration de dextran et deineura a la fin d'une heure
d'infusion, par la suite eleve; par contre, aucune varia-
tion significative de ces parametres ne fut prouvee sous
infusion de NaCl.
Le debit aortique foetal s'eleva parallelement ä l'index
cardiaque maternel en l'espace des premieres 30 minutes
sous dextran. II s'en suit, dans le Systeme circulatoire
foetal, au temps de mesure p 60, une elevation de debit
de 20% par rapport aux valeurs de depart.
Ces variations circulatoires sous hemodilution hypervo-
lemique furent prouvees par enregistrements originaux
par «Doppler-Shift-Signal» sur aorte descendante et vei-
ne ombilicale.
L'etroite relation hemodynamique entre les 2 systemes
circulatoires se reflete en une regression lineaire (r =
0,908) entre debit cardiaque maternel et flux aortique
foetal.
Discussion: Les premiers resultats, qui au moyen de la
combinaison de deux precedes non invasifs realisent une
exploration simultanee des systemes cardio-circulatoires
fcetaux et maternels, prouvent qu'il existe une correlation
entre Famelioration de la perfusion utero-placentaire
induite par «plasma-expander» et Pelevation du debit
foetal. Sous perfusion de memes quantites de solution
saline physiologique, on ne peut observer les memes
effets.
Tout en tenant compte du fait que ces resultats ont ete
observes sur un nombre limite de patientes, on peut
conclure que Fadministration en surplus de volume in-
travasal (en analogic aux experiences sur animaux de
SCHRÖCK [17]) conduit a une elevation du gradient
hydrostatique materno-foetal en faveur du foetus avec
augmentation proportionnelle entre le volume echange
et Felevations des volume et debit sanguins foetaux. La
poursuite des examens dans ce domaine doit confirmer
ces premieres experiences.
Mots-cles: Doppler, hemodilution hypervolemique, «impedanced cardiographie», mesures du flux de sang foetal,
preeclampsie.
References
[1] ASSALI, N. S., D. L. VAUGHN: Blood volume in pre-
eclampsia: Fantasy and reality. Am. J. Obstet. Gy-
necol. 129 (1977) 355
[2] BENEDETO, T., R. CARLSON: Studies of colloid os-
motic pressure on pregnancy-induced hypertension.
Am. J. Obstet. Gynecol. 135 (1979) 308
[3] CAMPBELL, S., J. DIAZ-RECASENS, D. R. GREFFIN:
New Doppler technique Tor assessing ute-
roplacental blood flow. Lancet i (1983) 675
[4] CLOEREN, S. E., T. H. LIPPERT, M. HINSELMANN:
Hypovolemia in toxemia in pregnancy: Plasma ex-
pander therapy with surveillance of central venous
pressure. Arch. Gynaekol. 215 (1973) 123
[5] GALLERY, E. D. M., S. N. HUNYOR, A. Z. GYÖRY:
Plasma volume contraction: A significant factor in
both pregnancy-associated hypertension (pre-
eclampsia) and chronic hypertension in pregnancy.
Q. J. Med. 192 (1979) 593
[6] GOODLIN, R. C., D. B. COTTON, H. C. HAESSLEIN:
Severe edema-proteinuria-hypertension gestosis.
Am. J. Obstet. Gynecol. 132 (1978) 595
[7] GOODLIN, R. C., C. A. DOBRY, J. C. ANDERSON,
R. E. WOODS, M. QUABFE: Clinical signs of plasma
volume expansion during pregnancy. Am. J. Obstet.
Gynecol. 145 (1983) 1001
J. Perinat. Med. 14 (1986)
Siekmann et al., Maternal cardiac output and fetal blood flow in pre-eclampsia 69
[8] GROENENDIJK, R., J. B. M. J. OUMBOS, H. C. S.
WALLENBURG: Hemodynamic measurements in pre-
eclampsia: Preliminary observations. Am. J. Obstet.
Gynecol. 150(1984)232
[9] HEILMANN, L., U. SDEKMANN: Die hypervolämische
Hämodilution bei der Präeklampsie. Infusionsther.
Klin. Ernaehr. 10 (1983) 311
[10] HEILMANN, L., U. SIEKMANN, H. SCHMID-SCHÖN-
BEIN, H. LUDWIG: Hemoconcentration and pre-
eclampsia. Arch. Gynecol. 231 (1981) 7
[11] JOUPPILA, P., P. KIRKINEN: Umbilical vein blood
flow as an indicator of fetal hypoxia. Br. J. Obstet.
Gynaecol. 91 (1984) 107
[12] JOUPPILA, P., R. JOUPPILA, A. KOIVULA: Albumin
infusion does not alter the intervillous blood flow
in severe pre-eclampsia. Acta Obstet. Gynecol.
Scand. 62 (1983) 345
[13] KIVIKOSKI, J., S. LUNDBOM, J. T. AIRAKSINEN: The
dextran concentration in the umbilical cord of a
newborn infant. Acta Anaesth. scand. [Suppl.] 24
(1966) 33
[14] KLOSA, W.: Noninvasive Messungen mit dem gepul-
sten Doppier-Verfahren in der fetoplazentaren Ein-
heit. In: KAISER, R. (ed.): Klinische Forschung in
der Gynäkologie und Geburtshilfe. Thieme, Stutt-
gart 1985
[15] KUBICEK, W. G., R J. KOTTKE, M. U. RAMOS, R. R
PATTERSON, D. A. WITSOE, J. W. LABREE, W. REMO-
LE, T. E. LANGMAN, H. SCHOENING, J. T. GARAMEL-
LA: The Minnesota Impedance Cardiograph —
theory and applications. Biomed. Engng. 9 (1974)
410
[16] LINDERKAMP, O.: Placental transfusion: Determi-
nants and effects. Clin. Perinatol. 9 (1982) 559
[17] SCHRÖCK, R.: Maternofetal water transfer during
hemodilution procedures in preeclampsia. 4th
World Congress of the ISSHIP, Amsterdam 1984
[18] SCHRÖCK, R., W. HEIMISCH, K. GEBHARDT, N.
MENDLER: Hemodilution as a therapeutic proce-
dure in EPH-gestosis. Bibl. Haematol. 47 (1981) 86
[19] SCHWARZ, R., U. RETZKE, K. D. SCHWARTZ, B.
POTSCHWADEK: Hämodynamische Prophylaxe der
drohenden intrauterinen Hypoxie. Zentralbl. Gy-
naekol. 95 (1973) 273
[20] SEGHAL, N. N., J. R. HITT: Plasma volume expan-
sion in the treatment of preeclampsia. Am. J. Ob-
stet. Gynecol. 138(1980) 165
[21] SIEKMANN, U.: Die Hämodynamik bei der Präe-
klampsie. In: KAULHAUSEN, H., J. SCHNEIDER:
Schwangerschaftsbedingte Hypertonie. Thieme,
Stuttgart 1983
[22] SIEKMANN, U., L. HEILMANN, H. LUDWIG: The ther-
apeutic value of plasma volume expansion in preg-
nancies with disturbed microcirculation. In: HEIL-
MANN, L., P. C. BUCHAN: Hcmorheological Dis-
orders in Obstetrics and Neonatology. Schattauer,
Stuttgart 1984
Received January 25,1985. Revised July 2,1985. Accept-
ed July 9, 1985.
PD Dr. med. U. Siekmann
Dept. of Obstetrics and Gynecology
University of Essen
Hufelandstr. 55
4300 Essen 1, Fed. Rep. Germany
J. Perinat. Med. 14 (1986)
Mcinclereircken
ici nenrosa
A Clinician's Guide to Treatment
1984.17 cm χ 24 cm. XIV, 251 pages.
Clothbound. DM 98 - ISBN 3110095319
Despite more than a century of ever-increasing scientific interest and research,
anorexia nervosa - the pathological pursuit of thinness - still presents a chal-
lenge to clinicians throughout the world. It has become practically impossible to
keep in touch with the constant proliferation of scientific literature on this sub-
ject. Moreover, the clinician (the general practitioner, the psychiatrist or the psy-
chologist) needs, first and foremost, practical guidelines for his everyday thera-
peutic work with these patients.
Therefore, two experienced clinicians, who are daily involved in research and
treatment of large numbers of anorexia nervosa patients, decided to write the
first book dealing extensively with the many practical issues one is faced with
when investigating and treating anorectic patients of all ages and in all stages of
their illness. No single treatment modality, psychotherapeutic, pharmacologic or
nutritional, has provided the final solution for the management of this intriguing
syndrome. Hence, the therapeutic approach described in this book is characte-
rized as an eclectic, broad spectrum or multimodal treatment in which strate-
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